| Term 
 | Definition 
 
        | non-selective NSAID Low dose: analgesic, antipyretic High dose: anti-inflammitory Acetylation and inhibition of COX 1 and 2 is irreversible Adverse effects GI tract (due to COX-1 inhibition) GI irritation -inhibition of cytoprotective PG's - PGE2, PGI2 Platelet inhibition Hepatic and renal toxicity Hypersensitivity - pruritis (itching) Tinnitus - altered hearing at toxic doses Reye's Syndrome: encephalopathy (brain disorder) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and anti-pyretic effects No anti-inflammitory activity No GI tract irritation Adverse effects Hepatotoxicity at high doses Metabolism by cytochrome P450 2E1 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective NSAID GI and renal adverse effects limit use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective NSAID Possibly associated with greatest toxicity overall used in the acute treatment of Gout |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective NSAID One of the least toxic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective NSAID associated with increased liver function abnormalities |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX-2 specific NSAID Safest for patients with high risk for GI bleeding May have increased risk of CV toxicity very expensive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute treatment of Gout Not first line anymore Produces anti-inflammitory effect by inhibiting leukocyte migration and phagocytosis (via inhibition of microtubule aggregation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthine oxidase inhibitor Blocks conversion of xanthine to uric acid standard agent for periods between acute attacks of Gout |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthine oxidase inhibitor Blocks conversion of xanthine to uric acid More selective than Allopurinol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric drug Promotes uric acid renal excretion - increases renal clearance by inhibiting tubular absorption Decreases the body pool of urate GI and kidney stone side effects may limit use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric drug Promotes uric acid renal excretion - increases renal clearance by inhibiting tubular absorption Decreases the body pool of urate GI and kidney stone side effects may limit use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD First line treatment of RA Inhibits AICAR transformylase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMAR Polypeptide antibiotic Inhibits interleukin-1 and interleukin-2 receptor production- interferes with cytokine signaling |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Cytostatic cross-link DNA to prevent cell replication |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Interferes with nucleic acid metabolism and synthesis and inhibits cell proliferation Suppresses B cell and T call function, immunoglobulin production and interleukin-2 secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Inhibits ribonucleotide synthesis and causes cell cycle arrest First agent for RA indicated for both symptomatic improvement and retardation of strucutral joint damage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Anti-malarial agent anti-inflammatory action in RA is unclear |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Anti-malarial agent anti-inflammatory action in RA is unclear |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Gold compound Alters the morphology and functional capabilities of human macrophages Not used much anymore |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD Gold compound Alters the morphology and functional capabilities of human macrophages Not used much anymore |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DMARD IgA and IgM rheumatoid factor production is decreased |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD Anti-TNF agent   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD anti-TNF agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD anti-TNF agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD B-cell depleting agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD T-cell costimulation inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biologic DMARD IL-1 inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute migraine drug Vasoconstriction due to stimulation of alpha-adrenergic and 5-HT receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute migraine drug Vasocontriction due to stimulation of alpha-adrenergic and 5-HT receptors ergotamine + caffeine - facilitates absorption of ergotamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute migraine drug Selective 5-HT1D and 5-HT1B receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute migraine drug Selective 5-HT1D and 5-HT1B receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narrow spectrum penicillin DOC for streptococci, meningococci, enterococci, penicillin-susceptible pneumococci and non-beta-lactamase producing staphylococci IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narrow spectrum penicillin indicated only in minor infections (poor bioavalibility, 4X day dosing and narrow spectrum of activity) PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antistaphylococcal penicillin treats serious beta-lactamase producing staph infections (acute endocarditis and osteomyelitis) Staph that are resistant to these penicillins are MRSA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extended spectrum penicillin greater activity against gram - bacteria treats UTIs, sinusitis, otitis and lower resp. tract infections often combined with beta-lactamase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extended spectrum penicillin greater activity against gram - bacteria treats UTIs, sinusitis, otitis and lower resp. tract infections often combined with beta-lactamase inhibitors often combined with gentamicin for the treatment of serious infections (enterococcal endocarditis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipseudomonal penicillin active against gram negative rods and gram + susceptible to beta-lactamases |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antipseudomonal penicillin active against gram negative rods and gram + susceptible to beta lactamases more effective against P. auroginosa then ticarcillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First generation cephalosporin does not cross BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First generation cephalosporin Does not cross BBB DOC for surgical prophylaxis and an alternative to penicillin in pts with allergies |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Second generation cephalosporin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Second generation cephalosporin treatment for CA pneumonia only 2nd generation that crosses BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Third generation cephalosporin less susceptible to beta-lactamases and can cross the BBB use can lead to psuedomembranous colitis (C.dif) used in combo with aminoglycoside to treat meningitis from P. aeruginosa active against N. gonorrhea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Third generation cephalosporin less susceptible to beta-lactamases and can cross the BBB use can lead to psuedomembranous colitis (C.dif) used in combo with aminoglycoside to treat meningitis from P. aeruginosa |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fourth genration cephalosporin more resistant to hydrolysis via beta-lactamases Highly active against H. influenzae and N. Gonorrhea Has the gram + coverage of a 1st generation and the gram - coverage of a 3rd generation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-Lactamase inhibitor very weak antibacterial activity only available in fixed combos with specific penicillins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-Lactamase inhibitor very weak antibacterial activity only available in fixed combos with specific penicillins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-Lactamase inhibitor very weak antibacterial activity only available in fixed combos with specific penicillins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Monobactam effective against gram negative bacilli Penicillin allergic patients tolerate it without rxn Side effect: bone marow suppression-induced leukopenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carbapenem wide spectrum with good activity against gram +, gram - rods and anaerobes activated by dehydropeptidases in the renal tubules 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial cell wall synthesis inhibitor active against gram + cocci and bacilli inhibits cell wall synthesis by interfering with elongation of the peptidoglycan backbone and cross-linking |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial cell wall synthesis inhibitor inhibits early stage of cell wall formation MOR - due to decreased transport of drug into bacteria gram + and gram - organisms Mainly used for UTIs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial cell wall synthesis inhibitor blocks regeneration of bactoprenol, a lipid carrier molecule that transfers PG subunits to the growing cell wall active aginst gram + cocci limited to topical use - too nephrotoxic for systemic use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial cell wall synthesis inhibitor inhibits the incorporation of D-alanine into peptidoglycan pentapeptide primarily used to treat multidrug resistant TB mycobacteria and gram - side effects - psychosis, sedation, confusion, vertigo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside binds to the 30S subunit - blocks protein synthesis Enzymatic modification is the most common MOR Renal, vestibular and neuromuscular toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside binds to the 30S subunit - blocks protein synthesis Enzymatic modification is the most common MOR Renal, vestibular and neuromuscular toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside binds to the 30S subunit - blocks protein synthesis Enzymatic modification is the most common MOR Renal, vestibular and neuromuscular toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside binds to the 30S subunit - blocks protein synthesis Enzymatic modification is the most common MOR Renal, vestibular and neuromuscular toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside binds to the 30S subunit - blocks protein synthesis Enzymatic modification is the most common MOR Renal, vestibular and neuromuscular toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline blocks 30S subunit by binding tRNA to the A site Broad spectrum and bacteriostatic MOR - bacteria gain efflux pumps by conjugation DOC for Rocky Mountain Spotted Fever and other Rickettsia infections DOC for borrelia induced lyme disease and relapsing fever May cause discoloration of the teeth and hypoplasia of the enamel in children under 8 Can cause phototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline blocks 30S subunit by binding tRNA to the A site Broad spectrum and bacteriostatic MOR - bacteria gain efflux pumps by conjugation DOC for Rocky Mountain Spotted Fever and other Rickettsia infections DOC for borrelia induced lyme disease and relapsing fever May cause discoloration of the teeth and hypoplasia of the enamel in children under 8 Can cause phototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline blocks 30S subunit by binding tRNA to the A site Broad spectrum and bacteriostatic MOR - bacteria gain efflux pumps by conjugation DOC for Rocky Mountain Spotted Fever and other Rickettsia infections DOC for borrelia induced lyme disease and relapsing fever May cause discoloration of the teeth and hypoplasia of the enamel in children under 8 Can cause phototoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide block 50S subunit by blocking peptidyl transferase MOR - efflux of drug out of bacteria and mutations in 50S subunit that decrease drug binding Potent inhibitor of P450s - drug interaction alert |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Affects the 50S ribosomal subunit Blocks peptidyl transferase (translocation step) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Affects the 50S ribosomal subunit Blocks peptidyl transferase (translocation step) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Affects the 50S ribosomal subunit Blocks peptidyl transferase (translocation step) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks peptidyl transferase broad spectrum antibiotic readily crosses the BBB - good for treating meningitis can induce fatal bone marrow suppression - this restricts its use to a few life-threatening infections MOR - mutations in ribosome binding site, mutations in porins decrease influx, plasmids encode for enzymes that degrade antibiotic Can cause Idiosyncratic aplestic anemia and Gray baby syndrome at high levels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Streptogramin Inhibits protein synthesis used for vancomycin resistant enterococcus very expensive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Streptogramin Inhibits protein synthesis used for vancomycin resistant enterococcus very expensive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oxazolidinone binds to the P site of the 50S subunit Gram + organisms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sulfonamide inhibit folate synthesis used for burn infections broad spectrum do not administer to pregnant women or newborns used as an antiparasitic drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sulfonamide blocks the synthesis of dihydrofolate used for occular infections and trachoma broad spectrum do not administer to pregnant women or newborns |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits Dihydrofolate reductase (DHFR) MOR - plasmid encodes resistant DHFR, mutation in DHFR, overexpression of DHFR used for bacterial prostatitis and vaginitis often used in combo with sulfamethoxazole |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | first generation Quinolone DNA gyrase inhibitor bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal) MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance limited gram - activity : UTIs only do not prescribe to children and pregnant women |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | second generation Quinolone DNA gyrase inhibitor bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal) MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance do not prescribe to children and pregnant women |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | third generation Quinolone DNA gyrase inhibitor bacteriostatic (but if bacteria cannot repair the damage can be bacteriacidal) MOR - DNA gyrase mutation, porin mutation, increased efflux - note: no plasmid mediated resistance do not prescribe to children and pregnant women |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Behaves as a free radical to disrupt replication, transcription and DNA repair Indicated for C. diff, H. pylori and D. medinensis Used prophylactically for surgical procedures antiparasitic activated under anaerobic conditions by PFOR disulfiram like effect - avoid alcohol consumption Trichomoniasis - sexual partners should be treated simultaneously Giardiasis - 90% success rate Amebiasis - DOC for treating symptomatic DZ |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cyclic lipopeptide disrupts membrane function in gram + organisms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks the formation of isoleucine-tRNAs most staph and strep strains incuding MRSA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits DNA dependent RNA polymerase MOR - mutations in RNA polymerase indicated for meningococcal carriers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for prophylaxis and treatment of UTIs can cause GI problems |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | disrupts cell membrane integrity often used in creams or ointments too nephrotoxic to give parenterally |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiparasitic effective at eliminationg E. histolytica from intestines mild or asymptomatic cases of amebiasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aminoglycoside antibiotic - inhibits protein synthesis effective at eliminating E. histolytica from intestine used to treat asymptomatic or mild cases of amebiasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Interference with PFOR treatment of Cryptosporidiosis and Giardiasis in individuals over 1 year of age |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiparasitic drug Inhibits DHFR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial half life in the body of 4 days eliminates asexual erythrocytic stages of all species of plasmodium BIG TIME resistance   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial drug poorest therapeutic:toxic ratio of all antimalarial drugs - cinchonism and hypoglycemia eliminates asexual erythrocytic stages of all species of plasmodium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial drug some reports demonstrate severe neuropsychiatric rxns in .5% of patients Effective against all species of plasmodium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial drug only drug that has activity against the liver (hypozoite) forms of P. vivax and P. ovale patients should be screened for G6PD - RBC lysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial drug treatment of P. falciparum malaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimalarial drug - tetracycline inhibits growth of plasmodium by disrupting protein synthesis major side effects - photosensitivity dermatitis and staining of teeth in children - contraindicated in children and pregnant women |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihelminthic - Benzimidazole ascariasis, pinworm, hookworm and whipworm infections |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihelminthic - Benzimidazole ascariasis, pinworm, hookworm and whipworm infections |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihelminthic - Benzimidazoles second line drug used in the treatment of strongyloidiasis used topically to treat cutaneous larval migrans |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihelminthic causes hyperpolarization in muscle cells - paralysis no affect on mammalian cells DOC for treating strongyloidiasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihelminthic activates cholinergic nicotinic receptors in nematodes - depolarizing neuromuscular blockade no effect on humans DOC for treating pinworms TREATMENT OF THE ENTIRE HOUSEHOLD IS RECOMMENDED |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tapeworm and Fluke infection Increase calcium permeability of the worm's tegument Flukes : 3 doses in a single day Tapeworms : a single dose Cysticercosis : two weeks treatment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Polyene antifungal Affinity for ergosterol sites - disrupt internal environment Main toxicity is renal Resistance is rare and slow to develop |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Block the production of ergosteol by inhibiting a demethylation step Significant inhibition of human CYP450 - drug interactions Liver toxicity   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Block the production of ergosteol by inhibiting a demethylation step Significant inhibition of human CYP450 - drug interactions Liver toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Block the production of ergosteol by inhibiting a demethylation step Significant inhibition of human CYP450 - drug interactions Liver toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Inhibition of cell wall synthesis - block production of chitin indicated for inavasive aspergillosis when other therapy fails |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Inhibition of cell wall synthesis - block production of chitin indicated for inavasive aspergillosis when other therapy fails |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Inhibition of nucleic acid synthesis (ultimately thymidylate synthase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal Squalene epoxidase inhibitor superficial infections |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal binds to tubulin to inhibit mitosis deposited in nails for superficial infections, but not used as much as Terbinafine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial DOC for the chemotherapy of TB Inhibits biosynthesis of mycolic acid Bacteriostatic for resting bacilli Bacteriocidal for dividing bacilli specifically activated by catalase-peroxidase Extensively metabolized by hepatic acetyltransferase drug induced hepatitis - rapid acetylators peripheral neuritis, SLE like symptoms - slow acetylators |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial inhibits RNA polymerase of bacilli hepatic activation broad spectrum used prophylactically in pts with isoniazid resistance most used with isoniazid for treatment of TB Hypersensitivity rxn in 50% of pts potential hepatitis discoloration of body fluids |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial used to treat M. avium intracellulare infections HIV+ pts   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial M. tuberculosis or M. avium used in resistant and HIV+ patients May alter vision (color discrimination) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial good for active TB infection inhibits fatty acid synthetase I must be used in combo therapy with other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacterial first drug used to treat TB not used much, only when resistant to other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial sulfone bacteriostatic inhibition of folic acid synthesis in M. leprae |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacterial bacteriostatic activity against M. leprae and MAC anti-inflammatory and immunologic activity erythema nodosum leprosum (skin lesions) highly lipophilic - long half life skin and body fluid discoloration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimycobacterial alleviates the presentation of erythema nodosum leprosum Teratogenic - babies born with missing limbs (phocomelia) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Parkinson's - blocks nicotinic cholinergic receptor viral infections - binds M2 membrane protein Not active against influenza B accelerates recover from fever if administered within 48 hours of exposure prophylacically to protect children and elderly from flu |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral inhibits neuraminidase of influenza A and B virus reduce the length of illness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral inhibits neuraminidase of influenza A and B virus reduce the length of illness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral prodrug - activated by herpesvirus thymidine kinase (binds to TK very specifically) inhibits DNA replication used for HSV-1 and VZV (chicken pox) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral prodrug - activated by viral phosphorylation potent vs. HSV and CMV low margin of safety - granulocytopenia and thrombocytopenia teratogenic and embryotoxic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral CMV, HSV-1 and 2 and VZV IV administration only CMV retinitis pts with AIDS and acyclovir resistant HSV infections in immunocompromised pts |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral nucleoside analog of thymidine and adenosine inhibit viral DNA synthesis limited to topical treatment of HSV and HPV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral nasal aerosol for RSV prodrug that must be phosphorylated disrupts purine metabolism - viral DNA synthesis inhibited contraindicated in pregnancy and lactation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antiviral used for viral hepatitis flu-like symtoms post-administration |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV NRTI 1st drug of its kind |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV Protease inhibitor N/V/D |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV Protease inhibitor N/V/D |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV Protease inhibitor N/V/D |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV Protease inhibitor 1st of its class - trials shortened due to efficacy N/V/D |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-HIV fusion (entry) inhibitor targets gp41 protein on HIV surface use in HIV+ pts who have developed resistance |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppresant Calcineurin inhibitor - blocks T cell activation prevention and treatment of acute organ rejection avoid tropical fruits and grapefruit nephrotoxicity and renal failure possible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosupressant calcineurin inhibition prophylaxis of acute rejection avoid grapefruit nephrotoxicity, hyperkalemia, hypomagnesemia, hyperglycemia (inhibits insulin release) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosupressant Antimetabolite inactivated by hepatic xanthine oxidase Leukopenia and thrombocytopenia May be contraindicated in pregnancy and breast feeding (risk D) Hepatotoxicity |  | 
        |  | 
        
        | Term 
 
        | Mycophenolate mofetil (CellCept) |  | Definition 
 
        | Immunosupressant Antimetabolite inhibits T cell and B cell proliferation prophylactic at time of transplant used in combo with steroids and calcineurin inhibitors use with caution in pregnancy and lactation (risk C) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppresant Antilymphocyte - reduces number and alters function of T-lymphocytes Major ADR: Hx of sensitivity to horse serum |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppresant Antilymphocyte horrible drug - produces anaphylactic rxns |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppresant antilymphocyte prophylaxis of acute renal rejection have epi pen ready: hypersensitivity rxns |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppresant antilymphocyte hydrocortisone pretreatment recommended - hypersensitivity rxns |  | 
        |  |